SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Aug-24 8:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 9,268 | $8.22 | $76,183.00 | (3%) 351.88K to 342.61K | (18%) |
22-May-24 6:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 9,268 | $9.10 | $84,338.80 | (3%) 361.15K to 351.88K | (7%) |
04-Apr-24 6:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 100,000 | -- | -- | 38% 260.68K to 360.68K | |
22-Feb-24 8:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 17,595 | $8.92 | $156,947.00 | (6%) 278.28K to 260.68K | (9%) |
22-Nov-23 6:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 7,363 | $10.37 | $76,354.30 | (3%) 285.64K to 278.28K | 6% |
22-Aug-23 6:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-23 | Payment of Exercise | 8,912 | $9.70 | $86,446.40 | (3%) 294.21K to 285.3K | (< 1%) |
23-May-23 7:44 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-23 | Payment of Exercise | 11,469 | $11.21 | $128,567.00 | (4%) 305.68K to 294.21K | |
03-Mar-23 10:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-Mar-23 | Grant | 75,000 | -- | -- | 33% 229.96K to 304.96K | |
22-Feb-23 7:23 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-23 | Payment of Exercise | 10,198 | $10.44 | $106,467.00 | (4%) 240.16K to 229.96K | 7% |